Clinical Forum

Join Pharmacy Times® Clinical Forum Events

Engage with experts in roundtable discussions on specialized therapeutic areas. Gain real-world insights and best practices from top institutions. Learn more

Health care worker examining lung x-ray

Additional Guidelines Around Biomarkers Could Improve Adjuvant Treatment of Early-Stage NSCLC

Erin Hunter, Assistant Editor
October 23rd 2023

The fast pace of information can make it difficult to efficiently apply data to care.

Image credit: dizain - stock.adobe.com.

With High Medication Burden of GVHD, Pharmacists Play a Critical Role in Supporting Education, Medication Adherence

Ashley Gallagher, Editor
August 15th 2023

Pharmacists can improve both quality of life and financial toxicity for patients.

Credit: MdBabul - stock.adobe.com

Advocacy, Education of Individuals With Myeloproliferative Neoplasms Are Important to Support Patient Engagement, Outcomes

Erin Hunter, Assistant Editor
August 14th 2023

Pharmacists also have the resources to help advocate for better care for patients.

steph photographies - stock.adobe.com

Pharmacists’ Involvement in Treatment Decisions for NSCLC Has Increased and Evolved

Aislinn Antrim, Managing Editor
June 16th 2023

A plethora of targeted therapies, biomarker-driven therapies, and immunotherapies are now available.

Data Show Melanoma Site to Be Independent High-Risk Factor for Recurrence, Poor Outcomes

Data Show Melanoma Site to Be Independent High-Risk Factor for Recurrence, Poor Outcomes

Alana Hippensteele, Lead Editor
February 24th 2023

High-risk areas for disease progression include genitalia and the scalp.

NSCLC May Be an Increasingly Biomarker-Driven Disease

NSCLC May Be an Increasingly Biomarker-Driven Disease

Alana Hippensteele, Lead Editor
February 23rd 2023

An expert shares information on risk factors and controversies around testing.

Pharmacists Can Provide Education on Management, Prevention Strategies for Chronic Graft-vs-Host Disease

Pharmacists Can Provide Education on Management, Prevention Strategies for Chronic Graft-vs-Host Disease

Aislinn Antrim, Managing Editor
February 22nd 2023

Pharmacologic approaches can reduce the risk of chronic GVHD.

<12
© 2025 MJH Life Sciences

All rights reserved.